(NewsDirect)
TEL AVIV andPittsburgh, McDadeProducts, LLC and G Medical Tests and Services, a division of G Medical Innovations HoldingsLtd (NASDAQ: GMVD), announced today a correction to their pressrelease issued January 14, 2022 in respect of shares acquired in theopen market by Dr. Yacov Geva, President and CEO of G MedicalInnovations, and Michael McDade, CEO of McDade Products, LLC. Instead,Dr. Geva and Mr. McDade each intend to acquire stock in the openmarket following the announcement, during the next available tradingwindow.
AboutMcDade Group
Founded in 1994, McDade Group is a growing and dynamic sales,marketing, and distribution services company headquartered inPittsburgh, PA. The company has expanded to provide solutions indistribution, category management, full-service merchandising, andconsulting across the U.S. retail industry. Many of the world’sleading CPG manufacturers rely on the ability of McDade Group to buildstrong industry relationships and deliver services, insights, andexpertise for hundreds of their products. Visit: https://www.mcdadegrp.com/ orLinkedIn: .
About G MedicalInnovations
GMedical Innovations Holdings Ltd. is an early commercial stagehealthcare company engaged in the development of next generationmHealth and telemedicine solutions and monitoring service platforms.The Company’s solutions and services can empower consumers, patientsand providers to better monitor, manage and improve clinical andpersonal health outcomes, especially for those who suffer fromcardiovascular disease (or CVD), pulmonary disease and diabetes. TheCompany’s current product lines consist of its Prizma medical device(or Prizma), a clinical grade device that can transform almost anysmartphone into a medical monitoring device enabling both healthcareproviders and individuals to monitor, manage and share a wide range ofvital signs and biometric indicators; its Extended Holter PatchSystem, a multi-channel patient-worn biosensor that captureselectrocardiography (or ECG) data continuously, including its QTSyndrome Prolongation Detection Capabilities Patch. In addition, theCompany is developing its Wireless Vital Signs Monitoring System (orVSMS), which is expected to provide full, continuous and real timemonitoring of a wide range of vital signs and biometrics. Itsmonitoring services include provision of Independent DiagnosticTesting Facility (or IDTF) monitoring services and private monitoringservices. Visit https://gmedinnovations.com/ .
Forward-LookingStatements
This press release contains forward-looking statements withinthe meaning of the “safe harbor” provisions of the PrivateSecurities Litigation Reform Act of 1995 and other Federal securitieslaws. Words such as “expects,” “anticipates,” “intends,”“plans,” “believes,” “seeks,” “estimates” and similarexpressions or variations of such words are intended to identifyforward-looking statements. For example, G Medical is usingforward-looking statements when it discusses the purchase of shares inthe open market by Dr. Geva and Mr. McDade. Because such statementsdeal with future events and are based on G Medical’s and McDadeProducts’ current expectations, they are subject to various risksand uncertainties, and actual results, performance or achievements ofG Medical and McDade Products could differ materially from thosedescribed in or implied by the statements in this press release. Theforward-looking statements contained or implied in this press releaseare subject to other risks and uncertainties, including thosediscussed under the heading “Risk Factors” in G Medical’sprospectus filed pursuant to Rule 424(b)(4), filed with the Securitiesand Exchange Commission (“SEC”) on June 28, 2021, and in anysubsequent filings with the SEC. Except as otherwise required by law,the companies undertakes no obligation to publicly release anyrevisions to these forward-looking statements to reflect events orcircumstances after the date hereof or to reflect the occurrence ofunanticipated events. References and links to websites have beenprovided as a convenience, and the information contained on suchwebsites is not incorporated by reference into this press release. GMedical and McDade Products are not responsible for the contents ofthird-party websites.
INVESTORRELATIONS CONTACT:
G Medical Innovations
Kobi Ben-Efraim, CFO
+972 8-958-4777
service@gmedinnovations.com
ContactDetails
Kobi Ben-Efraim, CFO
+972 8-958-4777
CompanyWebsite
Copyright (c) 2022 TheNewswire - All rights reserved.